321 related articles for article (PubMed ID: 29872429)
1. Past Life and Future Effects-How Heterologous Infections Alter Immunity to Influenza Viruses.
Souquette A; Thomas PG
Front Immunol; 2018; 9():1071. PubMed ID: 29872429
[TBL] [Abstract][Full Text] [Related]
2. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
4. Cellular immunity and memory to respiratory virus infections.
Woodland DL; Hogan RJ; Zhong W
Immunol Res; 2001; 24(1):53-67. PubMed ID: 11485209
[TBL] [Abstract][Full Text] [Related]
5. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
6. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
[TBL] [Abstract][Full Text] [Related]
7. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.
Che JW; Daniels KA; Selin LK; Welsh RM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807227
[TBL] [Abstract][Full Text] [Related]
8. Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host.
Yan AW; Cao P; Heffernan JM; McVernon J; Quinn KM; La Gruta NL; Laurie KL; McCaw JM
J Theor Biol; 2017 Jan; 413():34-49. PubMed ID: 27856216
[TBL] [Abstract][Full Text] [Related]
9. Human influenza viruses and CD8(+) T cell responses.
Grant EJ; Quiñones-Parra SM; Clemens EB; Kedzierska K
Curr Opin Virol; 2016 Feb; 16():132-142. PubMed ID: 26974887
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccines: 'tailor-made' or 'one fits all'.
Saletti G; Gerlach T; Rimmelzwaan GF
Curr Opin Immunol; 2018 Aug; 53():102-110. PubMed ID: 29734023
[TBL] [Abstract][Full Text] [Related]
11. Harnessing immune history to combat influenza viruses.
Guthmiller JJ; Wilson PC
Curr Opin Immunol; 2018 Aug; 53():187-195. PubMed ID: 29890370
[TBL] [Abstract][Full Text] [Related]
12. Imprinting, immunodominance, and other impediments to generating broad influenza immunity.
Knight M; Changrob S; Li L; Wilson PC
Immunol Rev; 2020 Jul; 296(1):191-204. PubMed ID: 32666572
[TBL] [Abstract][Full Text] [Related]
13. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.
Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM
Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203
[TBL] [Abstract][Full Text] [Related]
14. Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season.
Kim JH; Mishina M; Chung JR; Cole KS; Nowalk MP; Martin JM; Spencer S; Flannery B; Zimmerman RK; Sambhara S
J Infect Dis; 2016 Oct; 214(7):1030-8. PubMed ID: 27534687
[TBL] [Abstract][Full Text] [Related]
15. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
[TBL] [Abstract][Full Text] [Related]
16. Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.
Mohn KG; Cox RJ; Tunheim G; Berdal JE; Hauge AG; Jul-Larsen Å; ; Peters B; Oftung F; Jonassen CM; Mjaaland S
PLoS One; 2015; 10(11):e0143281. PubMed ID: 26606759
[TBL] [Abstract][Full Text] [Related]
17. Chronic spinal cord injury attenuates influenza virus-specific antiviral immunity.
Bracchi-Ricard V; Zha J; Smith A; Lopez-Rodriguez DM; Bethea JR; Andreansky S
J Neuroinflammation; 2016 May; 13(1):125. PubMed ID: 27245318
[TBL] [Abstract][Full Text] [Related]
18. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
19. [Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine].
Naĭkhin AN; Chirkova TV; Petukhova GD; Koren'kov DA; Donina SA; Rudenko LG
Vopr Virusol; 2012; 57(1):38-42. PubMed ID: 22624472
[TBL] [Abstract][Full Text] [Related]
20. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
